Organization | University of Ilorin

University of Ilorin Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

2010

NCT01030458

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2011

Timeline

NOW

Now

Alternative names

University of Ilorin, Ilorin, Nigeria | University of Ilorin Teaching Hospital

Active Ingredients

Drugs in Phase 4 Trials (4)

amlodipine (norvasc) (1 trial)

bisoprolol (zebeta) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 2 Trials (6)

amodiaquine (camoquin) (1 trial)

artesunate (1 trial)

mefloquine (lariam) (1 trial)

proguanil (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 10